Considering pathological GH conditions, metabolomic analysis of patients affected by acromegaly suggests that the main metabolic fingerprint of GH hypersecretion is a reduction in BCAAs, related to the disease activity [180]. The gene discussed is GH1; the disease is acromegaly.